![Sean Nolan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sean Nolan
Directeur Général chez
TAYSHA GENE THERAPIES, INC.
Fortune : 19 M $ au 30/06/2026
Profil
Sean P.
Nolan currently works at Taysha Gene Therapies, Inc., as Chairman & Chief Executive Officer from 2022, Nolan Capital LLC, as Chairman & President from 2019, Istari Oncology, Inc., as Chairman from 2018, Encoded Therapeutics, Inc., as Chairman from 2018, Affinia Therapeutics, Inc., as Chairman from 2019, Jaguar Gene Therapy LLC, as Executive Chairman from 2021, Ventas, Inc., as Independent Director from 2019, and John Carroll University, as Director.
Mr. Nolan also formerly worked at Novartis Gene Therapies, Inc., as President, Chief Executive Officer & Director from 2015 to 2018, Aquinox Pharmaceuticals, Inc., as Independent Director from 2015 to 2019, Neoleukin Therapeutics, Inc., as Director, Neoleukin Therapeutics, Inc., as Independent Director from 2015 to 2020, Social Capital Suvretta Holdings Corp.
II, as Independent Director from 2021 to 2023, Abbott Laboratories, as Principal, InterMune, Inc., as Chief Business Officer & Executive Vice President from 2013 to 2015, Reata Pharmaceuticals, Inc., as Chief Commercial Officer from 2011 to 2012, OVATION Pharmaceuticals, Inc., as Vice President-Marketing & Sales Operations from 2004 to 2009, and Lundbeck, Inc., as President & Chief Commercial Officer from 2009 to 2010.
Mr. Nolan received his undergraduate degree from John Carroll University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/03/2026 | 2 419 554 ( 0,89% ) | 16 M $ | 30/06/2026 | |
VENTAS, INC. 0,01% | 13/05/2026 | 26 181 ( 0,01% ) | 2 M $ | 30/06/2026 |
Postes actifs de Sean Nolan
| Sociétés | Poste | Début |
|---|---|---|
| VENTAS, INC. | Directeur/Membre du Conseil | 26/07/2019 |
| TAYSHA GENE THERAPIES, INC. | Directeur Général | 16/12/2022 |
Jaguar Gene Therapy LLC
 Jaguar Gene Therapy LLC Medical/Nursing ServicesHealth Services Provides gene therapy for patients | Président | 01/01/2021 |
Nolan Capital LLC | Président | 01/10/2019 |
Affinia Therapeutics, Inc.
 Affinia Therapeutics, Inc. BiotechnologyHealth Technology Develops adeno-associated virus gene therapies | Président | 01/12/2019 |
Istari Oncology, Inc.
 Istari Oncology, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology that focused on novel immuno-oncology and immunotherapy products | Président | 01/01/2018 |
Encoded Therapeutics, Inc.
 Encoded Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Encoded Therapeutics, Inc. operates as a biotechnology company that engages in the development of precision medicines and therapy for genetic disorders. It focuses on viral gene therapies. The company was founded by Kartik Ramamoorthi and Stephanie Tagliatela and is headquartered in South San Francisco, CA. | Président | 01/10/2018 |
John Carroll University
 John Carroll University Other Consumer ServicesConsumer Services Functions as a College/University | Directeur/Membre du Conseil | - |
Anciens postes connus de Sean Nolan
| Sociétés | Poste | Fin |
|---|---|---|
| SOCIAL CAPITAL SUVRETTA HOLDINGS CORP. II | Directeur/Membre du Conseil | 31/07/2023 |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Sean Nolan
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
62
Relations au 1er degré
18
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 18 |
|---|---|
Abbott Laboratories
 Abbott Laboratories Medical SpecialtiesHealth Technology Develops and manufactures medical devices, diagnostic systems, pharmaceuticals & nutritional products | Health Technology |
Ventas, Inc.
 Ventas, Inc. Real Estate Investment TrustsFinance Acquires and owns seniors housing and healthcare properties | Finance |
InterMune, Inc.
 InterMune, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that researches and develops therapies in pulmonology & orphan fibrotic diseases | Health Technology |
Reata Pharmaceuticals, Inc.
 Reata Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics which regulates cellular metabolism and inflammation in serious neurologic diseases | Health Technology |
John Carroll University
John Carroll University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OVATION Pharmaceuticals, Inc.
 OVATION Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceuticals | Health Technology |
Aquinox Pharmaceuticals, Inc.
 Aquinox Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in identification and development of therapeutics for inflammatory diseases and cancer | Health Technology |
Lundbeck, Inc.
 Lundbeck, Inc. Pharmaceuticals: MajorHealth Technology Produces pharmaceutical preparations | Health Technology |
Nolan Capital LLC | |
Novartis Gene Therapies, Inc.
 Novartis Gene Therapies, Inc. BiotechnologyHealth Technology Operates as a clinical-stage gene therapy company | Health Technology |
Istari Oncology, Inc.
Istari Oncology, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology that focused on novel immuno-oncology and immunotherapy products | Health Technology |
Neoleukin Therapeutics, Inc. /old/
 Neoleukin Therapeutics, Inc. /old/ Pharmaceuticals: MajorHealth Technology Develops medicines that transform lives | Health Technology |
Encoded Therapeutics, Inc.
Encoded Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Encoded Therapeutics, Inc. operates as a biotechnology company that engages in the development of precision medicines and therapy for genetic disorders. It focuses on viral gene therapies. The company was founded by Kartik Ramamoorthi and Stephanie Tagliatela and is headquartered in South San Francisco, CA. | Commercial Services |
Neoleukin Therapeutics, Inc.
 Neoleukin Therapeutics, Inc. BiotechnologyHealth Technology Develops de novo – therapeutic proteins to treat serious immunological disorders, including cancer and autoimmunity | Health Technology |
Affinia Therapeutics, Inc.
Affinia Therapeutics, Inc. BiotechnologyHealth Technology Develops adeno-associated virus gene therapies | Health Technology |
Taysha Gene Therapies, Inc.
 Taysha Gene Therapies, Inc. BiotechnologyHealth Technology Develops and commercializes adeno-associated viruses-based gene therapies for the treatment of monogenic diseases of the central nervous system | Health Technology |
Jaguar Gene Therapy LLC
Jaguar Gene Therapy LLC Medical/Nursing ServicesHealth Services Provides gene therapy for patients | Health Services |
Social Capital Suvretta Holdings Corp. II
 Social Capital Suvretta Holdings Corp. II Financial ConglomeratesFinance Operates as blank check company | Finance |
